Onychomycosis: Modern diagnostic and treatment approaches

被引:45
作者
Tchernev G. [1 ]
Penev P.K. [2 ]
Nenoff P. [3 ]
Zisova L.G. [4 ]
Cardoso J.C. [5 ]
Taneva T. [1 ]
Ginter-Hanselmayer G. [6 ]
Ananiev J. [7 ]
Gulubova M. [7 ]
Hristova R. [4 ]
Nocheva D. [4 ]
Guarneri C. [8 ]
Martino G. [8 ]
Kanazawa N. [9 ]
机构
[1] Polyclinic for Dermatology and Venerology, University Hospital Lozenetz, Academic Educational Hospital, 1407 Sofia
[2] Department of Dermatology and Venerology, Trakia University, Medical Faculty, 6000 Stara Zagora
[3] Haut- und Laborarzt/Allergologie, Andrologie, Labor für Medizinische Mikrobiologie, 04579 Mölbis
[4] Department of Dermatology and Venerology, Medical University Plovdiv, Plovdiv
[5] Dermatology and Venerology Department, University Hospital of Coimbra, 3000-075 Coimbra, Praceta Mota Pinto
[6] Department of Dermatology and Venerology, Medical University of Graz, 8036 Graz
[7] Department of General and Clinical Pathology, Medical Faculty, Trakia University, 6000 Stara Zagora
[8] Department of Social Territorial Medicine, Section of Dermatology, University of Messina, Gazzi, 98125 Messina, via Consolare Valeria
[9] Department of Dermatology, Wakayama Medical University, Wakayama
关键词
Antifungal therapy; Itraconazole; Laser treatment; MALDI-TOF MS; Onychomycosis; Terbinafine; Trichophyton rubrum; Uniplex-PCR-ELISA-Test;
D O I
10.1007/s10354-012-0139-3
中图分类号
学科分类号
摘要
The medical term onychomycosis should be understood as chronic infection of the nails caused by a fungus. The most common causative agents are the dermatophytes and Candida species. The less common are certain types of moulds (nondermatophyte moulds or NDMs). In approximately 60-80 % of the cases, onychomycosis is due to dermatophytes. Among dermatophytes, the most often isolated causative pathogen is Trichophyton (T.) rubrum. Other common species are T. interdigitale (formerly T. mentagrophytes), Epidermophyton floccosum, and T. tonsurans. The most significant yeasts causing onychomycosis are Candida albicans and Candida parapsilosis. Predisposing factors for onychomycosis include mainly diseases such as diabetes mellitus, peripheral vascular arterial disease, chronic venous insufficiency, polyneuropathies of diverse etiologies, and immunosuppression, e.g., myeloproliferative diseases (such as lymphoma and paraproteinemia), HIV/AIDS, etc. Other factors facilitating the fungal infection are frequent trauma in professional sportsmen, often accompanied by excessive perspiration. The diagnostic methods that are often applied in different dermatologic departments and ambulatory units are also different. This precludes the creation of a unified diagnostic algorithm that could be used everywhere as a possible standard. In most of the cases, the method of choice depends on the specialist's individual experience. The therapeutic approach depends mostly on the fungal organism identified by the dermatologist or mycologist. This review hereby includes the conventional as well as the newest and most reliable and modern methods used for the identification of the pathogens causing onychomycosis. Moreover, detailed information is suggested, about the choice of therapeutic scheme in case whether dermatophytes, moulds, or yeasts have been identified as causative agents. A thorough discussion of the schemes and duration of the antifungal therapy in certain groups of patients have been included. © 2012 Springer-Verlag Wien.
引用
收藏
页码:1 / 12
页数:11
相关论文
共 65 条
[1]  
Gupta A.K., Jain H.C., Lynde C.W., Prevalence and epidemiology of onychomycosis in patients visiting physicians, J Am Acad Dermatol., 43, pp. 244-248, (2000)
[2]  
Ghannoum M.A., Hajjeh R.A., Scher R., Konnikov N., Gupta A.K., Summerbell R., Et al., A large scale North American study of fungal isolated from nails
[3]  
The frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns, J Am Acad Dermatol., 43, pp. 641-648, (2000)
[4]  
Hamnerius N., Berglund J., Faergemann J., Pedal dermatophyte infection in psoriasis, Br J Dermatol., 150, pp. 1125-1128, (2004)
[5]  
Burzykowski T., Molenberghs G., Abeck D., High prevalence of foot disease in Europe
[6]  
Results of the Ahilese project, Mycoses., 46, pp. 496-505, (2003)
[7]  
Wolff K., Johnson R.A., Suurmond D., Fitzpatrick, (2005)
[8]  
Shemer A., Nathansohn N., Kaplan B., Trau H., Toenail abnormalities and onychomycosis in chronic venous insufficiency of the legs: Should we treat?, J Eur Acad Dermatol Venereol., 22, pp. 279-282, (2008)
[9]  
Gupta A.K., Gupta M.A., Summerbell R.C., The epidemiology of onychomycosis: Possible role of smoking and peripheral arterial disease, J Eur Acad Dermatol Venereol., 14, pp. 466-469, (2000)
[10]  
Ginter-Hanselmayer G., Weger W., Smolle J., Onychomycosis: A new emerging infectious disease in childhood population and adolescents. Report on treatment experience with terbinafine and itraconazole in 36 patients, J Eur Acad Dermatol Venereol, 22, pp. 470-475, (2008)